Elevated site urgencyFDA Class II

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Agency
FDA Drug
Recall date
Jun 4, 2026
Status
Ongoing
Company
Annora Pharma Private Limited

1. What product was recalled?

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Quantity: 31,392 60-count bottles

Code or lot text: Lot: A253999, A254000, Expires: 09/30/2027.

LOT
A254000
LOT
Expires: 09/30/2027.
LOT
Lot: A253999
NDC
31722-812
NDC
31722-812-05
NDC
31722-812-18
NDC
31722-812-32
NDC
31722-812-60
NDC
31722-813
NDC
31722-813-05
NDC
31722-813-18
NDC
31722-813-32
NDC
31722-813-60
NDC
31722-814
NDC
31722-814-05
NDC
31722-814-18
NDC
31722-814-32
NDC
31722-814-60
NDC
31722-815
NDC
31722-815-05
NDC
31722-815-18
NDC
31722-815-32
NDC
31722-815-60
RECALL-NUMBER
D-0626-2026
UPC
0331722812603
UPC
0331722813600
UPC
0331722814607
UPC
0331722815604

2. Is my exact product affected?

Compare every printed identifier. A matching value can indicate that your product is included.

3. What is the hazard?

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

4. What should I do now?

Follow the FDA recall notice and contact the recalling company for current instructions.

5. Where was it sold or distributed?

Nationwide

6. Were injuries or illnesses reported?

No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.

7. What remedy is available?

Follow the FDA recall notice and contact the recalling company for current instructions.

8. Is the recall active or closed?

The source status is Ongoing. Recall Index urgency is elevated, which is a separate deterministic site label.

9. When was the information checked?

Last checked .

  1. created

10. Where is the official source?

Open the official FDA Drug source

Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.